Go Pro

Attovia Therapeutics (ATTO) Insider Trading & Ownership

$21.17 -0.29 (-1.35%)
As of 12:15 PM Eastern

Attovia Therapeutics (NASDAQ:ATTO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.99%
Number Of
Insiders Buying
(Last 12 Months)
6
Amount Of
Insider Buying
(Last 12 Months)
$47.27M
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$4.50M
Get ATTO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Attovia Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATTO Insider Buying and Selling by Quarter

Attovia Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/6/2026
Colin Walsh
Colin Walsh
Director
Buy500,000$17.00$8,500,000.00  
8/6/2026
Global Strategic Fund I Venbio
Major Shareholder
Buy382,352$17.00$6,499,984.00  
8/6/2026
Goldman Sachs Group Inc
Major Shareholder
Buy500,000$17.00$8,500,000.00  
8/6/2026
Life Sciences Xi L.P. Frazier
Major Shareholder
Buy588,235$17.00$9,999,995.00  
8/6/2026
Redmile Group, Llc
Major Shareholder
Buy400,000$17.00$6,800,000.00  
8/6/2026
Redmile Group, Llc
Major Shareholder
Buy200,000$17.00$3,400,000.00  
8/5/2026
Colin Walsh
Colin Walsh
Director
Sell105,807$21.28$2,251,572.96  
8/5/2026
Colin Walsh
Colin Walsh
Director
Buy85,000$21.00$1,785,000.00  
8/5/2026
Goldman Sachs Group Inc
Major Shareholder
Sell105,807$21.28$2,251,572.96  
8/5/2026
Goldman Sachs Group Inc
Major Shareholder
Buy85,000$21.00$1,785,000.00  
(Data available from 1/1/2013 forward)

ATTO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Attovia Therapeutics includes Colin Walsh, Global Strategic Fund I Venbio, Goldman Sachs Group Inc, Life Sciences Xi L.P. Frazier, and Redmile Group, Llc. Learn more on insiders at ATTO.

0.99% of Attovia Therapeutics stock is owned by insiders. Learn more on ATTO's insider holdings.

The following insiders have purchased ATTO shares in the last 24 months: Colin Walsh ($10,285,000.00), Global Strategic Fund I Venbio ($6,499,984.00), Goldman Sachs Group Inc ($10,285,000.00), Life Sciences Xi L.P. Frazier ($9,999,995.00), and Redmile Group, Llc ($10,200,000.00).

Insiders have purchased a total of 2,740,587 ATTO shares in the last 24 months for a total of $47,269,979.00 bought.

The following insiders have sold ATTO shares in the last 24 months: Colin Walsh ($2,251,572.96), and Goldman Sachs Group Inc ($2,251,572.96).

Insiders have sold a total of 211,614 Attovia Therapeutics shares in the last 24 months for a total of $4,503,145.92 sold.

Attovia Therapeutics Active Insiders



This page (NASDAQ:ATTO) was last updated on 8/28/2026 by MarketBeat.com Staff.
From Our Partners